Fibrinogen: A Marker in Predicting Diabetic Foot Ulcer Severity
Table 1
Demographic and laboratory features of patients with patients and controls.
DFU patients ()
Control group ()
value
Age (years)
62.0 ± 10.3
0.054
Gender (F/M)
57 (37.5%)/95 (62.5%)
19 (36.5%)/33 (63.5%)
0.902
Duration of diabetes (years)
12.8 (11.6, 14.1)
11.3 (8.8, 13.7)
0.249
Smoking (%)
37.40%
38.90%
0.781
Drinking (%)
35.00%
30.60%
0.7
BMI (kg/m2)
25.09 (24.28, 25.90)
25.21 (22.17, 28.25)
0.941
SBP (mmHg)
145.5 ± 22.7
140.8 ± 18.6
0.262
DBP (mmHg)
79.0 ± 15.8
83.7 ± 10.8
0.099
FBG (mmol/L)
7.6 (7.1, 8.1)
8.2 (7.2, 9.3)
0.277
HbA1c (%)
8.56 (8.18, 8.94)
8.54 (7.13, 9.95)
0.975
Hemoglobin (g/L)
123.4 ± 21.7
139.2 ± 18.3
<0.0001
WBC (×109/L)
8.3 ± 3.8
6.7 ± 1.8
<0.0001
Neutrophil (×109/L)
6.00 ± 3.61
3.79 ± 1.27
<0.0001
Platelet (×109/L)
255.8 ± 79.5
233.5 ± 62.1
0.127
Fibrinogen (g/L)
4.50 ± 1.49
3.01 ± 1.07
<0.0001
Data were means ± SD or medians (interquartile range) or proportions for categorical variables. DFU: diabetic foot ulcer; SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; FBG: fasting plasma glucose; HbA1c: glycosylated hemoglobin; WBC: white blood cell.
